Volver a la clasificación

ExlService Holdings, Inc. (EXLS)

Infravalorada
TechnologyInformation Technology ServicesUnited States

Fundamental

76

Precio

$34.38

Capitalización Bursátil

$5.25B

Parte 1 · Cuánto vale la empresa

Resumen

ExlService Holdings (EXL) is a data and artificial-intelligence company that runs analytics and business processes on behalf of other companies. It sells two broad things: data and AI-led solutions — analytics, data management and digital engineering embedded into a client's workflow — and digital operations, meaning technology-enabled managed services where EXL takes over a repetitive back-office process such as insurance claims handling, healthcare payment integrity or finance and accounting. The work is delivered mostly from low-cost locations: of more than 65,000 employees at the end of 2025, roughly 43,200 were in India, 13,400 in the Philippines, 4,100 in South Africa and only about 2,900 in the United States, across 50-plus offices on six continents. Clients are concentrated in insurance, healthcare and life sciences, banking and capital markets; the company served approximately 590 clients in 2025.

Cómo genera ingresos

EXL sells services under master services agreements supplemented by individual statements of work. The mix runs from project-based engagements, typically shorter than a year, to long-term digital operations contracts that usually run three to five years. Revenue therefore arrives partly as recurring fees for running a process and partly as project fees for analytics and engineering work that must be re-won. There is no product licence and no hardware: revenue is essentially people and technology billed to the client, which is why employee costs and wage inflation sit at the centre of the margin story. In 2025 revenue was $2.09 billion, up 13.6% from $1.84 billion in 2024.

Ingresos por segmento

Insurance34%

Analytics and managed operations for property and casualty and life insurers: underwriting support, claims handling, subrogation and actuarial analytics. Revenue was $710.6 million in 2025, up 8.3% year on year — the largest segment but the slowest grower.

Healthcare and Life Sciences25.5%

Services for health payers, providers and pharmaceutical companies — payment integrity, care management analytics and commercial analytics for drugmakers. Revenue was $532.5 million in 2025, up 23.6%, the fastest-growing segment.

Banking, Capital Markets and Diversified Industries23.1%

Data, analytics and operations for banks, asset managers and non-financial corporates, including finance and accounting outsourcing and customer operations. Revenue was $482.4 million in 2025, up 13.0%.

International Growth Markets17.3%

Clients outside EXL's core United States base — the United Kingdom, Europe, Australia and other markets — served across the same industry offerings. Revenue was $362.2 million in 2025, up 11.6%.

Ventaja competitiva

Costes de cambio · Estrecha

Once EXL is running a client's claims queue or payment-integrity process under a three-to-five-year contract, the client has handed over trained staff, workflow knowledge and data pipelines; moving the work back in-house or to a rival is slow and disruptive, which is what keeps the long-term operations contracts sticky. That stickiness is real but narrow: EXL competes against much larger Indian and global IT-services firms on work that is ultimately labour arbitrage plus domain expertise, the contracts come up for renewal and reprice, and generative AI cuts both ways — it can raise the value EXL adds, or let a client do the same work with fewer outsourced people. The company's own filing warns that use of AI technology presents competitive, reputational and legal risks and may not be successful.

Qué impulsa la demanda

Moderadamente cíclico

Two different demands sit inside one company. The digital operations contracts run three to five years and cover work a client cannot stop doing — claims still have to be paid, invoices still have to be processed — so that revenue holds up through a downturn, and a recession can even push more work offshore as clients hunt for cost savings. The analytics and AI projects behave differently: they are discretionary technology budget, often under a year, and they are the first line item a client can defer when spending is cut. EXL itself flags that demand depends on anticipating the latest technology and can be affected by selling cycles. The result is a business that is steadier than pure consulting but more exposed than a regulated utility, with the sector mix — insurers and health payers, both defensive buyers — cushioning the swing.

Riesgos clave

  • Demand and keeping up with technology — The company states that its business depends on maintaining and growing client demand for its services and solutions, including by anticipating and incorporating the latest technology into its offerings; a significant reduction in that demand, a failure to respond to the evolving technological environment, or a change in how it delivers its services could materially affect results of operations.
  • The AI bet may not work — EXL discloses that the use of AI technology presents competitive, reputational and legal risks and that its use of AI technology may not be successful. It notes that the domestic and international legal and regulatory landscape around AI is rapidly evolving and uncertain, including on intellectual property, cybersecurity, and privacy and data protection.
  • Selling cycles and contract terms — The company warns that client demand may be impacted by the selling cycle and by the terms of its client contracts, including for its AI-related offerings — a reminder that signed work can be slow to convert into revenue and that contract terms sit with the buyer.
  • Hiring and retaining people — EXL states that it may fail to attract and retain enough sufficiently trained employees to support its operations, or professionals with sufficient leadership capabilities. With more than 65,000 employees, the workforce is the product being sold.
  • Wage increases squeeze the margin — The filing states that employee wage increases may prevent the company from sustaining its competitive advantage and may reduce its profit margin. Because the model rests on delivering from lower-cost locations, wage inflation in India and the Philippines erodes the gap the client is paying for.
  • Taxes, repatriation and cross-border regulation — The company warns that its financial condition could be negatively affected if governments in the countries where it operates introduce unfavourable tax legislation, including legal restrictions on repatriating earnings, and that its global operations subject it to numerous legal and regulatory requirements, including accreditation or licensing standards governing its business.

Concentración de clientes

Los principales clientes representan el 34% de los ingresos

The 10-K discloses that the top ten clients accounted for 34.0% of revenues in 2025, the top five for 23.9% and the top three for 17.8%, with no single client representing more than 10% of total revenues. The company served approximately 590 clients, each with annual revenue above $50,000. So the tail is long and no one customer can sink the year, but a third of the business still sits with ten relationships — losing or repricing one of them is felt.

Los argumentos a favor

Buyers argue that EXL sits on the right side of the AI shift rather than in front of it: it already holds the client's data and runs the workflow, so the tools that automate that work are tools EXL can sell back into an account it controls. They point to 2025 revenue of $2.09 billion, up 13.6%, with adjusted diluted earnings per share up 18.0% to $1.95, and to healthcare and life sciences growing 23.6% — evidence, they say, that the mix is tilting toward the faster, higher-value end rather than toward commodity back-office. They add that no client exceeds 10% of revenue, that the long-term operations contracts renew rather than have to be re-won each year, and that management guided 2026 revenue to $2.275–2.315 billion, 9–11% growth, while authorising a $500 million buyback over two years.

Los argumentos en contra

Sellers fear that the same technology feeding the growth story eventually eats the revenue line. The company bills for people — over 65,000 of them, some 43,200 in India — and if generative AI does what its promoters claim, the client needs fewer of those people for the same outcome, which shows up as price pressure at renewal rather than as lost logos. EXL's own filing concedes that its use of AI technology presents competitive, reputational and legal risks and may not be successful, and that employee wage increases may prevent it from sustaining its competitive advantage and may reduce its profit margin — the pincer sellers point to: costs rising in India while pricing falls. They also note that the largest segment, insurance at 34.0% of 2025 revenue, grew only 8.3%, slower than the group; that the analytics work is discretionary budget with long selling cycles the company itself flags; and that the delivery model concentrates operational, tax and repatriation exposure in a handful of emerging-market jurisdictions.

Generated on 18 de septiembre de 2026 with claude-haiku-4-5 — shared with all users

Direct competitors

Who this company fights with for the same customers

Compare

Generated on 18 de septiembre de 2026 with claude-haiku-4-5 — shared with all users

P/E: 12.5Score: 67Market cap: $27.09B

Listed among EXL's large global competitors, Cognizant bids for the same insurance, banking and healthcare-payer contracts covering claims, policy administration and analytics work.

Genpact LimitedG

Named by EXL in its own 10-K, Genpact is the closest like-for-like rival: both sell offshore-delivered digital operations plus data and AI services to insurers, banks and healthcare payers from the same India-centric delivery base.

Capgemini SE (owner of WNS since October 2025)CAP

Capgemini is named as a competitor in EXL's 10-K and, having absorbed WNS in October 2025, it now also owns EXL's historic head-to-head rival in insurance and banking process outsourcing.

Accenture plcACN

Named in EXL's 10-K, Accenture chases the same corporate budgets for operations outsourcing and AI-led transformation, usually entering through consulting and then taking over the running of the process.

Cotiviti, Inc.Not tracked

Named by EXL as a niche competitor, Cotiviti sells payment integrity and clinical analytics to the same US health insurers that buy EXL's healthcare offering; it is privately held by Veritas Capital and KKR.

Infosys LimitedINFY

Named in EXL's 10-K, Infosys competes through Infosys BPM for the same outsourced finance, insurance and customer-operations contracts, bundling them with its IT services relationships.

Balance y Liquidez

Ingresos

$2.16B

Últimos 12 meses (hasta 31/3/2026)

Beneficio Neto

$252M

Últimos 12 meses (hasta 31/3/2026)

Flujo de Caja Libre

$298M

Patrimonio Neto Total

$913M

Pasivo Total

$790M

Ratio de Liquidez

2.66

Cobertura de Intereses

18.78

Deuda/EBITDA

1.40

Beneficio Por Acción

Ingresos y Beneficio Neto

Flujo de Caja Libre

Desglose de Ingresos

Estado histórico

Márgenes en el tiempo

La deuda en el tiempo

Cuánto pesa la deuda

Cuadro de crecimiento

Crecimiento — Ingresos

Estimación de Valor Justo

Caso generalInfravalorado

Valor Justo

$52.72

Precio Actual

$34.38

Margen de Seguridad

+34.8%

Rango de Valor Justo

$34.27 - $71.17

Dispersión entre los métodos de valoración utilizados, no un intervalo de confianza calibrado estadísticamente.

Métodos de Estimación

Precio objetivo de los analistas:$44.63
Flujo de caja descontado (DCF):$96.45
Múltiplo sobre beneficios (P/E):$22.17
Fórmula de crecimiento de Graham:$79.75
Valor de la capacidad de generar beneficios (EPV):$18.48
P/B justificado:$22.22
Descuento de dividendos (Gordon):Datos insuficientes para calcularlo
P/FFO, fondos de operaciones:$32.49
Beneficios de mitad de ciclo:$39.67
Múltiplo sobre ingresos:$74.72
Consenso de Analistas:Compra Fuerte (15B / 1H / 0S)
Última Sorpresa de Resultados:+5.81%

Métricas de Valoración

Ratio P/E

21.90

ROE

27.5%

Ratio P/B

6.74

P/FCF

17.71

Margen Bruto

38.5%

ROIC

18.8%

Radar de Rentabilidad

Creación de Valor (Ventaja Competitiva)

ROIC

18.8%

WACC

8.7%

ROIC − WACC

+10.1 pp

El ROIC supera el coste del capital: la empresa está creando valor para los accionistas.

Criterios de Análisis Fundamental

Superado (23)

  • EPS shows upward trend
  • EPS CAGR 6.89%
  • Price CAGR 13.19%
  • ROIC 18.8%
  • Gross Margin 38.5%
  • P/FCF 17.71
  • Debt/Equity ratio
  • Operating Margin 15.2%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • ROE 28.5%
  • Revenue Growth 5Y 16.9%
  • Analyst Consensus 94% Buy
  • Earnings Surprise avg 4.7%
  • PEG Ratio 0.86
  • Earnings Quality (OCF/NI) 1.39
  • Share Dilution -0.5%
  • Net Margin Trend 11.7% vs 11.4%
  • Piotroski F-Score 7/9

Fallido (4)

  • P/B Ratio 6.74
  • Low reliance on intangibles
  • Price below Graham Number
  • DCF valuation (Overvalued)

No disponible (1)

  • Dividend Payout NaN%

Piotroski F-Score

7/9

Solidez financiera fuerte

score
criteria

Calidad de los Beneficios

1.39

Alta calidad: beneficios respaldados por efectivo

Dilución de Acciones

-0.5%

Recomprando acciones. Favorable para el accionista

Participaciones institucionales

Gobernanza

Equipo Directivo

NombreCargoEdad
Mr. Rohit KapoorCo-Founder, Chairman & CEO60
Mr. Vikas BhallaPresident and Head of AI Services & Operations53
Mr. Vivek JetleyPresident and Head of Insurance, Healthcare & Life Sciences50
Mr. Maurizio Nicolelli CPAExecutive VP & CFO57
Mr. Narasimha KiniExecutive Vice President of Banking & Capital Markets and Diversified Industries56
Ms. Bhavna Newle ChopraSenior Vice President in Operations Management-
Mr. Baljinder SinghExecutive VP, Global Chief Information Officer & Head of Enterprise Digital Transformation52
Mr. Andrew ThutHead of Investor Relations & Capital Markets-
Mr. Ajay Ayyappan J.D.Executive VP, General Counsel & Corporate Secretary47
Mr. Joel KatzSenior VP and Chief Compliance & Ethics Officer-

Riesgo de Auditoría

1

Riesgo del Consejo

5

Riesgo de Compensación

1

Riesgo de Derechos del Accionista

4

Parte 2 · El precio y el momento de entrar

Esta parte no sirve para saber si la empresa vale: sirve para elegir cuándo comprarla, una vez que los fundamentales te han convencido. Dentro: análisis técnico, potencial, caídas históricas, exposición gamma.

Documentos

  • Informe anual (10-K)

    Un resumen anual del negocio, los resultados financieros y los riesgos de la empresa.

    Presentado el 2026-02-24

    Ver documento
  • Informe trimestral (10-Q)

    Una actualización del desempeño financiero de los últimos tres meses.

    Presentado el 2026-07-28

    Ver documento
  • Informe de hecho relevante (8-K)

    Un aviso sobre un hecho relevante, como un cambio de dirección o un anuncio importante.

    Presentado el 2026-09-02

    Ver documento

via SEC EDGAR

Historial de Resultados

via SEC EDGAR

Latest News

Recent headlines for EXLS, sourced from Markets Gazette.

  • 3/11/2026NEGATIVE
    EXL Stock Down 41% Year Over Year as One Investor Reveals $68 Million Exit

    ExlService Holdings Inc. (EXLS) has experienced a significant 41% decline in its stock value over the past year. This downturn is highlighted by a substantial $68 million exit by a key investor, signaling a potential loss of confidence or a strategic shift. The company, which provides digital operations and analytics solutions to the insurance, healthcare, and life sciences sectors, faces increased scrutiny from the market. Investors are likely reassessing the company's growth prospects and competitive positioning in light of this exit and the substantial share price depreciation.

  • 2/25/2026NEUTRAL
    ExlService (EXLS) Q4 2025 Earnings Call Transcript

    Investors in ExlService (EXLS) are currently awaiting the release of the transcript from the company's fourth-quarter 2025 earnings call. While the event has been announced, specific details regarding key financial metrics such as revenue, earnings per share, and future guidance are not yet available. The market will closely scrutinize this information to assess the company's performance during the period and its growth prospects. The absence of concrete data currently prevents a directional judgment on the potential impact these results might have on the stock. The reaction of EXLS shares will entirely depend on the strength of the numbers presented and the future projections outlined by management.

via Markets Gazette